SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one-for-fifteen reverse stock split (the "Reverse Stock Split") of the Company's common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Thursday, March 20, 2025. The Company's common stock will continue to trade under Outset's ...

InfuSystem Holdings, Inc. (NYSE:INFU) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports fourth quarter and full ye ...

AdaptHealth Corp. (NASDAQ:AHCO) Q4 2024 Earnings Conference Call February 25, 2025 8:30 AM ET Company Participants Suzanne Foster – Chief Executive Officer Jason Clemens – Chief Financial Officer Conference Call Participants Ben Hendrix – RBC Capital Markets Mathew Blackman – Stifel Brian Tanquilut – Jefferies Richard Close – Canaccord Eric Coldwell – Baird Kieran Ryan – Deutsche Bank Operator Good day, everyone and welcome to today's AdaptHealth Fourth Quarter 2024 Earnings Release. Today's speakers will b ...

STERIS (STE) Q3 2025 Earnings Call February 06, 2025 09:00 AM ET Company Participants Julie Winter - Vice President of Investor Relations & Corporate CommunicationsMichael Tokich - Senior VP & CFODaniel Carestio - President and Chief Executive OfficerJacob Johnson - Managing Director Conference Call Participants Brett Fishbin - Vice President & Equity Research AnalystMichael Polark - Senior Equity Research AnalystJason Bednar - Senior Research AnalystPatrick Wood - AnalystMike Matson - Senior Equity Researc ...

Omnicell (OMCL) Q4 2024 Earnings Call February 06, 2025 08:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President, Investor RelationsRandall Lipps - Founder, Chairman, President and CEONchacha Etta - Executive VP & CFOScott Schoenhaus - Managing Director Conference Call Participants Allen Lutz - Senior Equity Research AnalystJessica Tassan - Senior Equity Research AnalystMatthew Hewitt - Senior Research AnalystStan Berenshteyn - Equity Research AnalystDavid Larsen - Analyst, Managing Director ...